The Cooper Companies found using ticker (COO) have now 10 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 560 and 280 with a mean TP of 364.5. Given that the stocks previous close was at 275.68 this would indicate that there is a potential upside of 32.2%. The day 50 moving average is 309.86 and the 200 day MA is 359.72. The market capitalisation for the company is $13,274m. You can visit the company''s website by visiting: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets="COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $17,551m based on the market concensus. The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.
The Cooper Companies with ticker code (COO) now have 11 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 560 and 280 and has a mean target at 366.82. With the stocks previous close at 291.45 this is indicating there is a potential upside of 25.9%. The 50 day MA is 311.81 and the 200 day moving average is 362.78. The market capitalisation for the company is $14,328m. You can visit the company''s website by visiting: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets="COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $18,033m based on the market concensus. The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.
The Cooper Companies with ticker code (COO) now have 11 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The target price ranges between 560 and 280 calculating the average target price we see 366.82. Given that the stocks previous close was at 314.7 this is indicating there is a potential upside of 16.6%. There is a 50 day moving average of 313.4 while the 200 day moving average is 365.23. The company has a market capitalisation of $15,727m. Company Website: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets="COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $18,332m based on the market concensus. The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.
The Cooper Companies with ticker code (COO) now have 11 analysts in total covering the stock. The consensus rating is ''Buy''. The target price ranges between 560 and 295 with the average target price sitting at 371.82. Given that the stocks previous close was at 300.12 this would indicate that there is a potential upside of 23.9%. The 50 day moving average now sits at 314.45 and the 200 moving average now moves to 367.22. The market cap for the company is $14,580m. Visit the company website at: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets="COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $18,064m based on the market concensus. The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Research analysts at Oppenheimer cut their FY2023 earnings per share estimates for Cooper Companies in a research note issued on Thursday, September 1st. Oppenheimer analyst S. Lichtman now … Read Full Story at source (may require registration) The post Equities Analysts Issue Forecasts for The Cooper Companies, Inc.’s FY2023 Earnings (NYSE:COO) appeared first on ForexTV .
Cooper Companies Inc''s (NYSE: COO ) Q3 FY22 revenues increased 10% Y/Y to $843.4 million , up 18% in constant currency and 9% organically, beating the consensus of $832.68 million. The CooperVision (CVI) segment revenue increased 2% to $566.3 million, and CooperSurgical (CSI) revenue up 35% to $277.1 million. Adjusted EPS of $3.19 was down 6% Y/Y, missing the consensus of $3.24. The adjusted gross margin was 66%, down from 68% … Full story available on Benzinga.com
The Cooper Companies press release (COO): Q3 Non-GAAP EPS of $3.19 misses by $0.04.Revenue of $843.4M (+10.5% Y/Y) beats by $13.18M.Fiscal Year 2022 Financial GuidanceThe…
The Cooper Companies (COO) is scheduled to announce Q3 earnings results on Wednesday, August 31st, after market close.The consensus EPS Estimate is $3.23 (-5.3% Y/Y) and the consensus…
Cooper Companies (NYSE: COO ) is set to give its latest quarterly earnings report on Wednesday, 2022-08-31. Here''s what investors need to know before the announcement. Analysts estimate that Cooper Companies will report an earnings per share (EPS) of $3.24. Cooper Companies bulls will hope to hear the company to announce they''ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for … Full story available on Benzinga.com
The Cooper Companies found using ticker (COO) have now 11 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 560 and 310 with the average target price sitting at 405.09. Given that the stocks previous close was at 296.57 this now indicates there is a potential upside of 36.6%. There is a 50 day moving average of 315.38 and the 200 moving average now moves to 369.66. The company has a market capitalisation of $14,372m. You can visit the company''s website by visiting: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets="COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $19,631m based on the market concensus. The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Needham expects Cooper Companies Inc (NYSE: COO ) to miss F3Q22 consensus revenue and EPS estimates due to unfavorable currency, lockdowns in China, and incremental interest expense when it releases earnings next week. The analyst also expects the management to lower its FY22 revenue and EPS guidance to account for macro headwinds and FY22 Myopia Management revenue expectations due to currency and lockdowns in China. When Needham initiated coverage, the Hold thesis was based on the limited upside to estimate of a high-single-digit EPS CAGR through FY24. "While we believe Cooper Companies can … Full story available on Benzinga.com
The Cooper Companies found using ticker (COO) now have 12 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 560 and 310 calculating the average target price we see 406.75. Now with the previous closing price of 322.69 this would indicate that there is a potential upside of 26.0%. The 50 day moving average now sits at 316.68 and the 200 day MA is 372.77. The company has a market capitalisation of $15,512m. Company Website: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets="COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $19,553m based on the market concensus. The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Baron Funds, an asset management firm, published its “Baron Health Care Fund” second quarter 2022 investor letter – a copy of which can be downloaded here. In the quarter ended June 30, 2022, Baron Health Care Fund (the “Fund”) declined 10.00% (Institutional Shares), compared with the 7.43% decline for the Russell 3000 Health Care Index (the […]
The Cooper Companies found using ticker (COO) have now 12 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 560 and 310 with a mean TP of 407.58. Given that the stocks previous close was at 313.44 this would indicate that there is a potential upside of 30.0%. There is a 50 day moving average of 322.01 and the 200 day MA is 381.14. The market capitalisation for the company is $15,477m. Find out more information at: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets="COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $20,126m based on the market concensus. The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Looking at the universe of stocks we cover at Dividend Channel, on 7/26/22, Fastenal Co. (Symbol: FAST), Cooper Companies, Inc. (Symbol: COO), and AptarGroup Inc. (Symbol: ATR) will all trade ex-dividend for their respective upcoming dividends. Fastenal Co. will pay its quarte
The Cooper Companies with ticker code (COO) now have 12 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 560 and 310 and has a mean target at 407.58. Given that the stocks previous close was at 293.51 this indicates there is a potential upside of 38.9%. The day 50 moving average is 323.55 while the 200 day moving average is 383.71. The market capitalisation for the company is $14,512m. Company Website: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets="COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $20,152m based on the market concensus. The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.
The Cooper Companies (NYSE:COO) declares $0.03/share semi-annual dividend, in line with previous.Forward yield 0.02%Payable Aug.
New Jersey, USA -- ( SBWIRE ) -- 07/05/2022 -- The latest study released on the Global Surgical Retractors Market by AMA Research evaluates market size, trend, and forecast to 2027. The Surgical Retractors market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analyzed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors. Key Players in This Report Include: Johnson & Johnson (United States), Medtronic Plc (United States), Becton, Dickinson, And Company (United States), Stryker Corporation (United States), Terumo Corporation (Japan), Henry Schein, Inc. (United States), B. Braun Melsungen Ag (Germany), Teleflex Incorporated (United States), Integra Lifesciences Holdings Corporation (United States), The Cooper Companies, Inc. (United States) Download Sample Report PDF (Including Full TOC, Table & Figures) @ https://www.advancemarketanalytics.com/sample-report/38546-global-surgical-retractors-market Definition: Surgical retractors is defined as the surgical instrument, which is widely used to separate the edges of a surgical incision.
The Cooper Companies with ticker code (COO) have now 11 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 560 and 335 with the average target price sitting at 421. With the stocks previous close at 313.12 this is indicating there is a potential upside of 34.5%. There is a 50 day moving average of 338.25 and the 200 day moving average is 390.21. The company has a market cap of $15,714m. Find out more information at: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets="COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $21,128m based on the market concensus. The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.
The Cooper Companies found using ticker (COO) have now 11 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 535.57 and 320.38 calculating the mean target price we have 406.98. With the stocks previous close at 305.16 this would imply there is a potential upside of 33.4%. The day 50 moving average is 355.13 and the 200 day MA is 396.27. The company has a market cap of $15,045m. Find out more information at: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets="COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $20,064m based on the market concensus. The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2022 investor letter – a copy of which can be downloaded here.
The Cooper Companies found using ticker (COO) now have 11 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The target price ranges between 560 and 335 calculating the average target price we see 425.55. Given that the stocks previous close was at 332.35 this now indicates there is a potential upside of 28.0%. The 50 day MA is 365.99 and the 200 moving average now moves to 399.69. The market capitalisation for the company is $15,795m. Visit the company website at: https://www.coopercos.com [stock_market_widget type="chart" template="basic" color="green" assets="COO" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $20,224m based on the market concensus. The Cooper Companies, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Cooper Companies presents with balanced factors on both sides of the risk/reward calculus. we are trigger shy on COO and prefer to wait before further action on this name.
COO earnings call for the period ending March 31, 2022.
The Cooper Companies, Inc. (NYSE:NYSE:COO) Q2 2022 Results Conference Call June 02, 2022 5:00 PM ET Company Participants Kim Duncan - VP, IR & Risk Management Albert White - President,…
Cooper Companies (COO) has revised its fiscal year 2022 revenue guidance to $3.28B-$3.31B from prior guidance of $3.26B-$3.31B.
The Cooper Companies press release (NYSE:COO): Q2 Non-GAAP EPS of $3.24 misses by $0.19.Revenue of $829.8M (+15.3% Y/Y) beats by $8.77M.
SAN RAMON, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO) today announced financial results for its fiscal second quarter ended April 30, 2022.
The Cooper Companies (COO) is scheduled to announce Q2 earnings results on Thursday, June 2nd, after market close.The consensus EPS Estimate is $3.43 and the consensus Revenue Estimate…
Cooper Companies (NYSE: COO ) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 4 0 0 0 Last 30D 0 1 0 0 0 1M Ago 1 2 0 0 0 2M Ago 0 0 0 0 0 3M Ago 0 1 0 0 0 In the last 3 months, 5 analysts have offered 12-month price targets for Cooper Companies. The company has an average price target of $425.8 with a high of $500.00 and a low of $380.00. Below is a summary of how these 5 analysts rated Cooper Companies over the past 3 months. … Full story available on Benzinga.com
This report studies the Vision Care Market with many aspects of the industry such as market size, market status, market trends and forecast. The report also provides brief information on competitors and opportunities for specific growth with the key market drivers. Find the comprehensive analysis of the Vision Care market segmented by company, region, type []
Cooper Companies, Inc. (COO) shares closed today at 1.4% below its 52 week high of $415.96, giving the company a market cap of $21B. The stock is currently up 11.2% year-to-date, up 39.5% over the past 12 months, and up 127.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.4%, and the S&P 500 rose 0.2%. Trading Activity Trading volume this week was 31.1% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.7. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 185.6% The company's stock price performance over the past 12 months beats the peer average by 536.5% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -88.2% lower than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Coherent Market Insights has announced the addition of the Global Contact Lens Market Size, Status and Forecast 2027, The report classifies the market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as
Corum Group (DTEK), the largest manufacturer of mining equipment in Ukraine, is entering the Turkish market. The first contract was signed with the leading coal mining company Imbat Madencilik for the pilot supply of KD90T 17.5/28 roof supports. Entering new markets is one of the key directions of the company, approved within the framework of[] The post Ukrainian mining equipment supplier Corum enters Turkish coal market with pilot contract for roof supports appeared first on International Mining .
Cooper Cos. stock outperforms competitors on strong trading day MarketWatch
The Corum Group on Tuesday donated G$1 million to the Civil Defence Commission (CDC) to aid flood relief efforts and to provide support to the families and communities affected by the catastrophic floods. Presenting the cheque was Iman Cummings, Director of Communications and Business Development at the Corum Group. According to Cummings, the Corum Group []
WASHINGTON (dpa-AFX) - The Cooper Companies, Inc. (COO) revealed a profit for its second quarter that climbed from the same period last year.The company''s earnings totaled $117.5 million, or $2.36
Earnings results for The Cooper Companies , Analyst Opinion on The Cooper Companies , Earnings and Valuation of (NYSE:COO), Stock market Insights & financial analysis, Best stock to invest, Investment Idea, The post Analysts Estimate Report : What to Look Out for The Cooper Companies (NYSE:COO) appeared first on .
Market Analysis and Insights: Global Contact Lenses Market Contact lenses market is expected to be growing at a growth rate of 5.20% in the forecast period of 2020 to 2027. Contact lenses market report analyses the growth, which is currently being
Cooper Cos will be reporting Q2 earnings on June 3. Wall Street analysts expect Cooper Cos will be reporting earnings per share of $3.09. Go here to track Cooper Cos stock price in real-time ahead of earnings. On June 3,
Cooper Cos will be reporting Q2 earnings on June 3. Wall Street analysts expect Cooper Cos will be reporting earnings per share of $3.09. Go here to track Cooper Cos stock price in real-time ahead of earnings. On June 3,…
DUBLIN, May 20, 2021 /PRNewswire/ -- The "Global Contact Lens Market With Focus on Cosmetic Lens: Size, Trends & Forecasts (2021-2025 Edition)" report has been added to ResearchAndMarkets.com''s offering. The global contact lens market has witnessed continuous growth in the past few years
Cooper Companies, Inc. shares closed 0.5% higher than its previous 52 week high, giving the company a market cap of $21B. The stock is currently up 10.0% year-to-date, up 34.6% over the past 12 months, and up 156.0% over the past five years. This week, the Dow Jones Industrial Average rose 1.2%, and the S&P 500 rose 1.4%. Trading Activity Trading volume this week was 17.7% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 86.9% The company's stock price performance over the past 12 months beats the peer average by 151.4% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -116.0% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Cooper Companies, Inc. shares closed today at 0.5% below its 52 week high of $401.92, giving the company a market cap of $20B. The stock is currently up 7.6% year-to-date, up 30.2% over the past 12 months, and up 154.6% over the past five years. This week, the Dow Jones Industrial Average rose 0.9%, and the S&P 500 rose 1.2%. Trading Activity Trading volume this week was 33.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 163.0% The company's stock price performance over the past 12 months beats the peer average by 201.8% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -116.2% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
ROCHESTER, N.Y., March 18, 2021 /PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that CooperVision, a unit of The Cooper Companies, Inc. (NYSE: COO), one…
Contact Lens Market report is an in-depth analysis study offered which explains necessary aspects like competition, segmentation, and regional growth in excessive detail. As a part of competitive analysis, the analysis study includes thorough company identification of leading players of
Cooper Cos. reported better-than-expected fiscal 1Q results, driven by higher revenues and improved margins. The post Cooper’s 1Q Results Beat The Street Consensus; Street Says Buy appeared first on Smarter Analyst .
This Future Market Insights (FMI) report examines the ‘Global OrthokeratologyMarket for the period 2013–2028. The primary objective of the report is to offer updates and information related to market opportunities in the Global Orthokeratology Market. The Orthokeratology Market segmented as follows: OrthokeratologyMarket,
Cooper Companies Inc. shares closed today at 1.5% below its 52 week high of $396.86, giving the company a market cap of $20B. The stock is currently up 6.3% year-to-date, up 19.0% over the past 12 months, and up 170.4% over the past five years. This week, the Dow Jones Industrial Average fell 1.7%, and the S&P 500 fell 2.5%. Trading Activity Trading volume this week was 22.7% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -763.4% The company's stock price performance over the past 12 months beats the peer average by 144.9% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -253.6% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
Cooper Companies Inc. shares closed today at 0.7% below its 52 week high of $393.43, giving the company a market cap of $20B. The stock is currently up 6.9% year-to-date, up 9.3% over the past 12 months, and up 176.2% over the past five years. This week, the Dow Jones Industrial Average rose 0.2%, and the S&P 500 fell 0.7%. Trading Activity Trading volume this week was 40.6% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.9. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 2713.1% The company's stock price performance over the past 12 months beats the peer average by -414.6% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 244.4% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.